Haisco Pharmaceutical Group Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
1/10
|
81.81 | 69.4 | 17.88% | 61.93 | +32.11% |
| P/S |
|
7.02 | 6.51 | 7.88% |
|
|
| P/BV |
|
6.28 | 3.96 | 58.74% |
|
|
| P/FCF |
|
0 | 0 | 0% |
|
|
| Ev/Ebitda |
|
60.17 | 11.85 | 407.83% |
|
|
| Ev/S |
|
8.19 | 5.98 | 37.04% |
|
|
| Ev/FCF |
|
0 | 0 | 0% |
|
|
| E/P |
|
0.0114 | 0.0396 | -71.21% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
1/10
|
4.68 | 16.34 | -71.36% | 19.67 | -76.21% |
| ROE |
|
11.37 | 11.95 | -4.82% |
|
|
| ROA |
|
1.55 | 5.4 | -71.31% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
9.08 | 16.23 | -44.06% |
|
|
| ROCE |
|
0 | 0 | 0% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
0/10
|
7.58 | 14.63 | -48.15% | 5.61 | +35.28% |
| Nеt Debt/Ebitda |
|
0 | 0 | 0% |
|
|
| Debt/Ratio |
|
0 | 0 | 0% |
|
|
| Debt/Equity |
|
0 | 0 | 0% |
|
|
| Debt/Net Income |
|
6.55 | 3.6 | 81.81% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
2.1/10
|
0.84 | 1.83 | -54.17% | 1.34 | -37.35% |
| Number of years of dividend growth |
|
0 | 1.44 | -100% | ||
| DSI |
|
0.7143 | 0.9113 | -21.62% |
|
|
| Average dividend growth |
|
-6.44 | 10.4 | -161.99% |
|
|
| Average percentage for 5 years |
|
1.34 | 1.14 | 17.41% |
|
|
| Average percentage for payments |
|
65.45 | 44.8 | 46.1% |
|
|
| Difference from average difference in sector |
|
-0.993 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-14.79 | 61.43 | -124.08% | ||
| Growth impulse Ebitda in 5 years |
|
44.98 | 158.62 | -71.64% | ||
| Growth impulse Net Income in 5 years |
|
-40.25 | 66.93 | -160.14% | ||
| Growth impulse FCF in 5 years |
|
-67.75 | 248.41 | -127.27% | ||
| Growth impulse EPS in 5 years |
|
73.79 | 73.29 | 0.6822% |
IP Score
3.78/10
